Ultrasound imaging for suspected pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study is collecting information from people who may have pancreatic cancer to see how a new ultrasound imaging technique (called LINFU) works for helping doctors decide whether a biopsy is needed. Participation could provide better imaging to guide your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 89 years old.
- You must be suspected of having pancreatic cancer because you have symptoms (like jaundice, weight loss, or belly pain) or because an imaging test suggests it.
- You must be scheduled for or have had an imaging test close to the procedure (within a set time frame), like an endoscopy ultrasound, MRI, or CT scan.
- You must not have already been diagnosed with pancreatic cancer through a biopsy or other test.
- You must not have a type of pancreatic cyst called IPMN.
- You must not be pregnant, and you must not have a known allergy to the contrast agent or secretin used in the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at healthy adults who have no symptoms or risk factors for pancreatic cancer to test a new imaging method that may help find early signs of the disease. If you join, you will have an endoscopic ultrasound (a thin tube with a camera passed to your stomach) to check your pancreas.
This trial studies whether adding focused ultrasound (a treatment that uses sound waves to target the tumor) to standard chemotherapy can help shrink or control pancreatic cancer in people whose cancer is borderline resectable or locally advanced. It aims to see if this combination is more effective than chemotherapy alone.
This study looks at how doctors use endoscopic ultrasound (EUS) to diagnose and manage tumors in the pancreas and nearby areas. If you have such a tumor, this study may help improve how these conditions are treated.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
This study tests new ultrasound methods to better see the pancreas and thyroid. It includes people at high risk for pancreatic cancer, those with pancreatic cancer, those with a thyroid nodule, and healthy volunteers.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.